Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2012

Aug 20, 2012

30826_dirs_2012-08-20_11df810e-6661-45f7-9ee3-186d625a7fe8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2012-08-16

Reporting Person: GRIFFITH MICHAEL A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-16 Common Stock P 1600 $4.880 Acquired 1600 Direct
2012-08-16 Common Stock P 200 $4.879 Acquired 1800 Direct
2012-08-16 Common Stock P 200 $4.868 Acquired 2000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $4.53 2022-05-24 Common Stock (24000) 24000 Direct

Footnotes

F1: 8,000 shares vest and become exercisable on each of the following dates: 5/24/2013, 5/24/2014 and 5/24/2015.